Abstract
We report a patient who ingested 500 ml of Hexastar 5.5% EC™, a hexaconazole-containing product. Clinical toxicity consisted primarily of central nervous system depression and generalized trembling. The patient recovered without sequelae with supportive therapy.
Keywords: :